JP2017520550A5 - - Google Patents

Download PDF

Info

Publication number
JP2017520550A5
JP2017520550A5 JP2016573925A JP2016573925A JP2017520550A5 JP 2017520550 A5 JP2017520550 A5 JP 2017520550A5 JP 2016573925 A JP2016573925 A JP 2016573925A JP 2016573925 A JP2016573925 A JP 2016573925A JP 2017520550 A5 JP2017520550 A5 JP 2017520550A5
Authority
JP
Japan
Prior art keywords
reaction mixture
acid
substituent
facbc
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016573925A
Other languages
English (en)
Japanese (ja)
Other versions
JP6997519B2 (ja
JP2017520550A (ja
Filing date
Publication date
Priority claimed from GBGB1411569.5A external-priority patent/GB201411569D0/en
Application filed filed Critical
Publication of JP2017520550A publication Critical patent/JP2017520550A/ja
Publication of JP2017520550A5 publication Critical patent/JP2017520550A5/ja
Application granted granted Critical
Publication of JP6997519B2 publication Critical patent/JP6997519B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016573925A 2014-06-30 2015-06-30 新規製剤及び合成方法 Active JP6997519B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1411569.5 2014-06-30
GBGB1411569.5A GB201411569D0 (en) 2014-06-30 2014-06-30 Novel formulation and method of synthesis
PCT/EP2015/064796 WO2016001199A1 (en) 2014-06-30 2015-06-30 Novel formulation and method of synthesis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020114659A Division JP2020172518A (ja) 2014-06-30 2020-07-02 新規製剤及び合成方法

Publications (3)

Publication Number Publication Date
JP2017520550A JP2017520550A (ja) 2017-07-27
JP2017520550A5 true JP2017520550A5 (enExample) 2020-02-13
JP6997519B2 JP6997519B2 (ja) 2022-02-04

Family

ID=51410328

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016573925A Active JP6997519B2 (ja) 2014-06-30 2015-06-30 新規製剤及び合成方法
JP2020114659A Pending JP2020172518A (ja) 2014-06-30 2020-07-02 新規製剤及び合成方法
JP2022095283A Active JP7657759B2 (ja) 2014-06-30 2022-06-13 新規製剤及び合成方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020114659A Pending JP2020172518A (ja) 2014-06-30 2020-07-02 新規製剤及び合成方法
JP2022095283A Active JP7657759B2 (ja) 2014-06-30 2022-06-13 新規製剤及び合成方法

Country Status (18)

Country Link
US (1) US11077216B2 (enExample)
EP (2) EP3160923B1 (enExample)
JP (3) JP6997519B2 (enExample)
KR (1) KR102381616B1 (enExample)
CN (1) CN106458785B (enExample)
AU (1) AU2015283054B2 (enExample)
BR (1) BR112016030350B1 (enExample)
CA (1) CA2953641C (enExample)
DK (1) DK3431460T3 (enExample)
ES (1) ES2710073T3 (enExample)
GB (1) GB201411569D0 (enExample)
IL (1) IL249348A0 (enExample)
PL (1) PL3160923T3 (enExample)
PT (1) PT3160923T (enExample)
RU (1) RU2016147507A (enExample)
SG (1) SG11201610883QA (enExample)
TR (1) TR201901460T4 (enExample)
WO (1) WO2016001199A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220001034A1 (en) * 2014-06-30 2022-01-06 Ge Healthcare Limited Novel formulation and method of synthesis
US12180581B2 (en) 2017-09-18 2024-12-31 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
US12181452B2 (en) 2017-09-18 2024-12-31 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
US11709155B2 (en) 2017-09-18 2023-07-25 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes
US11709156B2 (en) 2017-09-18 2023-07-25 Waters Technologies Corporation Use of vapor deposition coated flow paths for improved analytical analysis
GB201805253D0 (en) * 2018-03-29 2018-05-16 Ge Healthcare Ltd Ip Solid phase extraction
GB201915206D0 (en) 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer
US11918936B2 (en) 2020-01-17 2024-03-05 Waters Technologies Corporation Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding
EP4628889A3 (en) 2020-09-24 2025-12-10 Waters Technologies Corporation Chromatographic hardware improvements for the separation of reactive molecules

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1356827A1 (en) 2002-04-24 2003-10-29 Mallinckrodt Inc. Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution
US7993626B2 (en) 2007-01-11 2011-08-09 Immunomedics, Inc. Methods and compositions for F-18 labeling of proteins, peptides and other molecules
SG177216A1 (en) 2003-07-24 2012-01-30 Bracco Imaging Spa Stable radiopharmaceutical compositions and methods for their preparation
GB0422004D0 (en) 2004-10-05 2004-11-03 Amersham Plc Method of deprotection
AU2006262425C1 (en) 2005-06-23 2012-06-21 Emory University Stereoselective synthesis of amino acid analogs for tumor imaging
WO2007063824A1 (ja) 2005-11-29 2007-06-07 Nihon Medi-Physics Co., Ltd. 放射性ハロゲン標識有機化合物の前駆体化合物
AU2007251015B2 (en) 2006-05-11 2011-09-01 Nihon Medi-Physics Co., Ltd. Process for production of radioactive fluorine-labeled organic compound
AU2007335633A1 (en) 2006-12-21 2008-06-26 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic imaging agent
EP2119458B9 (en) 2007-02-13 2013-08-21 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
EP2658831B1 (en) 2010-12-29 2017-02-15 GE Healthcare Limited Eluent solution
GB201117785D0 (en) 2011-10-14 2011-11-30 Ge Healthcare Ltd Improved radiosynthesis method
GB2509476B (en) 2011-12-21 2018-08-08 Ge Healthcare Ltd Ip 18F - Fluciclovine compositions in citrate buffers
GB201205703D0 (en) 2012-03-30 2012-05-16 Ge Healthcare Ltd Synthon composition
GB201214220D0 (en) 2012-08-09 2012-09-19 Ge Healthcare Ltd Radiosynthesis

Similar Documents

Publication Publication Date Title
RU2016147507A (ru) Новая композиция и способ синтеза
JP2022043078A5 (enExample)
JP2022551185A5 (enExample)
JP6356876B2 (ja) 抗ウイルス化合物の合成
AU2007287070C1 (en) Substituted acylanilides and methods of use thereof
JP2015537020A5 (enExample)
JP2013032389A5 (enExample)
AR088296A1 (es) Citramida de rasagilina, proceso de preparación y composicion farmaceutica
JP2013500304A5 (enExample)
CY1113873T1 (el) Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90
RU2013140169A (ru) Противоопухолевое терапевтическое средство
JP2020520946A5 (enExample)
JP2012532883A5 (enExample)
JP2015535847A5 (enExample)
JP2014519488A5 (enExample)
Verkade P (RNCH2CH2) 3N: Very strong non-ionic bases useful in organic synthesis
Fang et al. SH2 Decarboxylative Monofluoromethylation of Aliphatic Carboxylic Acids Enabled by Nickel/Photoredox Dual Catalysis
ES2686929T3 (es) Procedimiento de resolución óptica para compuesto bicíclico utilizando catalizador asimétrico
CN111302980A (zh) 含硫酰氟基团的氨基酸类似物及其制备方法和应用
JP2015509966A5 (enExample)
JP2016515564A5 (enExample)
CN111212824B (zh) 酮的定向β-C(sp3)-H碘化和芳基化
RU2015138540A (ru) Способ радиоактивного мечения
CN106029654A (zh) 通过环化2-(氨基乙氧基)苯甲酸衍生物制备3,4-二氢-1,4-苯并氧氮杂环庚三烯-5(2h)-酮衍生物
NZ727574B2 (en) Novel formulation and method of synthesis